PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Spiracur secures USD20.3m in series B funding

Spiracur, a US-based medical device company that designs and develops damaged tissue care solutions, has secured USD20.3m in a series B round of venture capital funding led by Kleiner P

Spiracur, a US-based medical device company that designs and develops damaged tissue care solutions, has secured USD20.3m in a series B round of venture capital funding led by Kleiner Perkins Caufield & Byers and New Leaf Venture Partners.

Existing investor De Novo Ventures also participated in the round.

Kleiner Perkins Caufield & Byers, New Leaf Venture Partners and De Novo Ventures are US-based venture capital firms.

Previously, Spiracur raised USD4m in venture capital funding.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured